Assistant Professor
University of Florida
Dr. Guo conducts research in pharmacoepidemiology and pharmacoinformatics, primarily focused on cardiometabolic diseases and neurodegenerative conditions (e.g., dementia) with the goals of promoting precision health and health equity. Her research draws on large real-world data (e.g., electronic health records and insurance claims data) and advanced analytics (e.g., AI/machine learning, causal-principled modeling, and geospatial analyses) to: 1) assess comparative effectiveness/safety and heterogeneous treatment effects (HTEs) of treatments and interventions, and 2) develop individualized and intelligent social risk management tools to be integrated into clinical care. Dr. Guo has published over 90 peer-reviewed manuscripts. Several articles have been published in top-tier journals, including Diabetes Care, Lancet and BMJ, and featured in media outlets, including Washington Post, NPR, and CNN. Her research programs and collaborations have been funded by the NIH, Veterans Affairs, CDC, FDA and the PhRMA Foundation.